Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Insmed Incorporated, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Kura Oncology Inc. June 5, 202585.5%
-
Immunome Inc. June 12, 202477.1%
-
Insmed Incorporated May 13, 202488.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 13, 2026 | Insmed Incorporated | Grant or award | +3,305 | — | — |
| May 15, 2025 | Insmed Incorporated | Grant or award | +5,058 | — | — |
| May 13, 2024 | Insmed Incorporated | Grant or award | +13,162 | — | — |
| May 11, 2023 | Insmed Incorporated | Grant or award | +13,192 | — | — |
Questions about Carol Schafer
What boards is Carol Schafer on?
Carol Schafer sits on the boards of Immunome Inc., Insmed Incorporated and Kura Oncology Inc.
How long has Carol Schafer served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.